Some standard content:
GB16853—1997
This standard is proposed in accordance with the requirements of the "Law of the People's Republic of China on the Prevention and Control of Communicable Diseases", with reference to the technical indicators for tuberculosis monitoring approved by the International Tuberculosis Surveillance Research Committee (TSRU), and based on the monitoring indicators for tuberculosis epidemics and prevention and control measures in the "National Tuberculosis Prevention and Control Manual" (1991 edition) approved by the Department of Health and Epidemic Prevention (now the Department of Disease Control) of the Ministry of Health, combined with the practice and experience of implementing tuberculosis monitoring in 26 provinces, municipalities, autonomous regions, and 84 districts and counties since 1986. The survey on the "annual infection rate" in the tuberculosis epidemic monitoring indicators is a relatively important indicator for judging the tuberculosis epidemic and an indicator that is in line with the world's tuberculosis monitoring. In view of the fact that BCG vaccination is currently being carried out nationwide, the determination method is yet to be unified. Appendix A of this standard is the appendix to the standard. This standard is proposed by the Ministry of Health of the People's Republic of China. This standard is drafted by the Tuberculosis Control Center of the Ministry of Health. The main drafters of this standard are: Li Zhengmin, Duanmu Hongjin, and Song Wenhu. The technical unit of this standard is the Office of Supervision and Administration of Communicable Disease Prevention and Control of the Ministry of Health. 48.1bZxz.net
1 Scope
National Standard of the People's Republic of China
Surveillance standards of tuberculosis
Surveillance standards of tuberculosis This standard specifies the surveillance standards of tuberculosis, including epidemic surveillance indicators and prevention and control measures surveillance indicators. This standard is applicable to tuberculosis prevention and control institutions at all levels and serves as the basis for local tuberculosis epidemic surveillance. 2 Referenced standards
GB16853-1997
The provisions contained in the following standards constitute the provisions of this standard through reference in this standard. When this standard is published, the versions shown are valid. All standards will be revised, and the parties using this standard should explore the possibility of using the latest versions of the following standards. GB15987-1995 Diagnostic standards and treatment principles for infectious pulmonary tuberculosis 3 Definitions
This standard adopts the following definitions.
3.1 Tuberculosis Epidemic Monitoring Indicators
3.1.1 Annual infection rate: indicates the frequency of natural tuberculosis infection in a certain area and a certain population within one year, expressed in %. 3.1.2 Registration rate of active pulmonary tuberculosis patients and registration rate of smear-positive pulmonary tuberculosis: indicates the frequency of active pulmonary tuberculosis patients and smear-positive pulmonary tuberculosis patients registered at the end of a year in a certain area and a certain population, expressed in 1/100,000. 3.1.3 New registration rate of active pulmonary tuberculosis patients and new registration rate of smear-positive pulmonary tuberculosis patients: indicates the frequency of newly registered active pulmonary tuberculosis patients and the frequency of newly registered smear-positive pulmonary tuberculosis patients in a certain area and a certain population within a certain year, expressed in 1/100,000. 3.1.4 Incidence rate of tuberculous meningitis aged 0-14 years: indicates the frequency of tuberculous meningitis among children aged 0-14 years in a certain area within one year, expressed in 1/100,000.
3.1.5 Tuberculosis (pulmonary tuberculosis) mortality rate: indicates the frequency of death due to tuberculosis (pulmonary tuberculosis) in the total population of a certain region and a certain population in a certain year, expressed as 1/100,000.
3.1.6 The ranking of tuberculosis deaths among various causes of death: in health statistics, various causes of death are often arranged in order according to their mortality rates. Generally, the top ten causes of death are regarded as common causes of death. 3.2 Monitoring indicators for tuberculosis prevention and control measures
3.2.1 Infectious source discovery rate: refers to the percentage of the number of newly registered smear-positive pulmonary tuberculosis patients in a certain region in a certain year to the estimated number of newly registered smear-positive pulmonary tuberculosis patients in that year.
3.2.2 Treatment results and outcomes of smear-positive pulmonary tuberculosis patients Cohort analysis calculates the treatment results and outcomes (including cure, failure to cure, death, migration, loss, completion of treatment without sputum results, and others) of all smear-positive patients in a certain region at the end of the prescribed course of treatment within a year, expressed as %. 3.2.3\BCG vaccination rate for infants under one year old: refers to the frequency of infants under one year old receiving BCG vaccination in a certain area within one year, expressed in %.
Approved by the State Administration of Technical Supervision on June 10, 1997 and implemented on January 1, 1998
4 Monitoring indicators and calculation formulas
4.1 Monitoring indicators for tuberculosis epidemic
4.1.1 Annual infection rate
Annual infection rate (%) 2
GB16853--1997
-Number of tuberculin positive reactions in a year × 100Number of original tuberculin negative reactions
(1)
4.1.2 Registration rate of active pulmonary tuberculosis patients
Registration rate of active pulmonary tuberculosis patients (1/100,000) = Number of active pulmonary tuberculosis patients registered in a year × 10,000 ( 2) Population at the end of the year
4.1.3 Registration rate of smear-positive pulmonary tuberculosis patients
Number of smear-positive pulmonary tuberculosis patients registered at the end of the year, registration rate of smear-positive pulmonary tuberculosis patients (1/100,000) =
X 100,000
Number of annual population
4.1.4 New registration rate of active pulmonary tuberculosis patients....(3)
, number of newly registered active pulmonary tuberculosis patients in the year × 100,000 new registration rate of active pulmonary tuberculosis patients (1/100,000) =4.1.5 New registration rate of smear-positive pulmonary tuberculosis patients
Average annual population
New registration rate of smear-positive pulmonary tuberculosis patients (1/10 10,000) = Number of newly registered tuberculosis patients in the year × 100,000 average annual population
(5)
4.1.60 Tuberculous meningitis incidence rate for children aged 14 years and under (1/100,000) Number of cases of tuberculous peritonitis for children aged 14 years and under × 100,000 average annual number of children aged 14 years and under
4.1.7 Tuberculosis mortality rate
Number of deaths due to tuberculosis in the year
Tuberculosis mortality rate (1/100,000)
×100,000
Average annual population
4.1.8 Pulmonary tuberculosis mortality rate
, Number of deaths due to pulmonary tuberculosis in the year × 10,000 Pulmonary tuberculosis mortality rate (1/100,000)
4.2 Monitoring indicators for tuberculosis prevention and control measures
4.2.1 Infection source detection rate
Infection source detection rate (%) =
Annual average population
Number of newly registered smear-positive pulmonary tuberculosis patients
Estimated number of newly smear-positive pulmonary tuberculosis patients
Estimated number of newly smear-positive patients × Annual average population × Smear-positive pulmonary tuberculosis incidence rate (7)
·(8)
?(10)
Smear-positive pulmonary tuberculosis incidence rate: refers to the number of newly diagnosed smear-positive pulmonary tuberculosis patients per 1,000 people in a certain area and a certain population within a unit of time (usually one year). When calculating, the number of newly diagnosed smear-positive pulmonary tuberculosis patients is divided by the number of observed people and expressed as %. Incidence rate of smear-positive pulmonary tuberculosis (%) Number of new tuberculosis patients during the observation period × 1000 Number of observation person-years
BCG vaccination rate for infants under one year old
BCG vaccination rate for infants under one year old (%) = Number of vaccinations for infants under two years old × 100-Number of infants under one year old
..(11)
Table A1 Province, Municipality, Autonomous Region
Age (years old)
GB16853—1997
Appendix A
(Standard Appendix)
Tuberculosis Monitoring Report
County Tuberculosis Monitoring Area
Annual Population Data Report
Instructions for filling in the form: If there is no population grouping data for the year, the current county population number can be multiplied by the age and sex ratio of the local population census data in 1990 to estimate the current year's population number of different ages and sexes. Please indicate the details. 487
Table A2 Provinces, municipalities and autonomous regions
End of previous year
Number of patients
Only Peiyang
Pulmonary tuberculosis
Extrapulmonary tuberculosis
Number of patients increased during the year
Number of patients newly registered during the year
New cases and relapses
GB 16853--1997
Annual report on registration of active pulmonary tuberculosis patients in county monitoring areasNumber of patients reduced during the year
(1)+(2)+(3)+(4)+(5)+(6)-(7)-(8)-(9)- (10)-(11)-(12) -- (13)=(14). (The sputum bacterial grouping for items (7) to (14) is the same as that for items (1) to (6) (i.e., no group change). 2
Item (15) is the classification of the results of sputum examinations that have not been performed in the year. 3
4For the concepts in the table, please refer to the "National Tuberculosis Prevention and Control Manual". Table A3 Province, city, autonomous region
Age group
Instructions for filling in the form
Only active pulmonary tuberculosis patients in Peiyang
County have not been registered in the year Record negative
"Smear positive\refers to the sum of patients with smear (+) culture (+), smear (+) culture (+) and simple smear (+). 2"Culture positive only\refers to the number of patients with smear (+) culture (+), 3"Negative" refers to the sum of patients with smear, culture (+) and simple smear (+) (no culture). 4Analysis object is the same as Table A2, item 15,
Active patient disease type classification
Age group
Instructions for filling in the form
GB 16853-1997
Table A4 Province, city, autonomous region
Number of newly registered patients in the year (new plus relapse) only Peiyang
County newly registered active pulmonary tuberculosis report in the year Number of newly registered patients in the year (excluding relapse) Active patients Disease type classification
TuChuyang
Subtotal Male
"Smear positive\refers to the sum of patients with smear (+) and smear (+), smear (+) and smear (+)"Only Peiyang\refers to patients with smear (+) and smear (+) 10) Number of patients. 2
3“Negative bacteria\refers to the sum of patients with smear and culture (I) and simple smear (I) (without culture). Only culture positive
Table A5 Sputum examination of newly registered patients diagnosed in the year Number of newly registered patients in the year
Of which: Tian, N type
Simple smear number
(+) number
(I) number
Chu (+)
Culture (-)
Instructions for filling in the form:“ The number of patients with simple smears refers to the number of patients who only underwent sputum smears but not sputum cultures. Smear plus culture results
Tu (+)
Culture (+)
Classification of disease types of active patients
Chu ()
Culture (+)
Table A6 Newly registered patients within 6 years Discovery and treatment\delay" situation January～
<15 days
[5 days～
Discovery delay
Medical staff
Discovery total delay
Treatment delay
Total delay in discovery and treatment
February～
, March～April～
Chu（—）)
May～
>June「Subtotal
Discovery delay
Medical staff
Total delay in discovery
Treatment delay
Total delay in discovery and treatment
Form filling instructions
In the item of “discovery delay”
GB 16853—1997
Table A6 (end)
<15 days15 days～
1 month～
(1) Patient delay: refers to the time from the onset of symptoms to the first visit to the doctor2 months～
(2) Medical staff delay: refers to the time from the patient's first visit to the doctor to the diagnosis of pulmonary tuberculosis;(3) Total detection delay: refers to the time from the patient's onset of symptoms to the diagnosis of pulmonary tuberculosis;3 months一
(4) The number of subtotals of patient delay, medical staff delay, and total detection delay should be the same. 2 Treatment delay refers to the time from the diagnosis of pulmonary tuberculosis to the start of treatment. 3 Total detection and treatment delay; refers to the time from the onset of symptoms to the start of treatment. 4 Cases with a delay time of \0\ are all placed in the *<15 days" column. Annual report of new registered patients found in the year Table A7
Only culture positive
Total number of patients
Instructions for filling in the form
Seeking medical treatment due to symptoms
and referral
and census
Contacts
Table A8 One-year outcome cohort analysis of newly diagnosed sputum-positive patients Cured
Non-tuberculosis
May 1
Strong tuberculosis
Completed treatment
No sputum result
The total number of patients filled in the table is the number reported to the center by each point last year The number of newly diagnosed sputum-positive patients in Table A2 (excluding relapses). 2 Cured: patients with sputum-positive status turned negative after completing the course of treatment. 3 Uncured: patients with sputum-positive status still tested positive for sputum after completing the course of treatment for one year. Death: deaths from tuberculosis (including pulmonary and extrapulmonary tuberculosis), deaths caused by non-tuberculosis. 4
5 Migrated out of the county: patients who have moved out of the county and will no longer visit the county tuberculosis prevention and control center (department) for treatment or follow-up. 6 Lost: patients who have refused treatment or examination after multiple follow-ups or whose whereabouts have been unknown for one year. 7 Completed treatment with no sputum results: patients who completed the prescribed course of treatment but had no sputum results or only had one negative sputum smear result. Those who cannot be included in the above items should be included in the "other" item. Cases in the "other" item should be separately Indicate the reasons for inclusion and the number of patients. 8
9 If a short-course chemotherapy regimen is used, the items in Table A8 are the results of a full course of treatment. 490
Number of live births
Number of people sampled
GB16853—1997
Newborn BCG vaccination in the year
Number of people vaccinated with BCG
Intradermal method
Table A10 Card marks and card establishment for children aged 12 months Number of people with card marks
Table A11
Incidence of tuberculous encephalitis aged 0 to 14 years (number of people)
Instructions for filling in the form: If there are no cases of tuberculous encephalitis after the investigation, Write \0" in both male and female columns. Table A12
BCG type:
Number of people vaccinated
Test reaction
Manufacturing unit:
Newborn BCG vaccination 12 weeks positive conversion reaction diameter, mm
13~～
Reaction diameter, mm
Vaccination method:
Type of antigen:
Manufacturing unit:
Number of people with complications from BCG vaccination
Table A13
Ulcers that have not healed for more than 6 months
Note: "Other" should indicate the name of the disease.
Keloid
Allergic purpura
Osteomyelitis
Scratch method
Number of people with cards
Lymph node enlargement
Defective changes
Acute lung disease
Cor pulmonale
Nuclear surgery
Renal tuberculosis
Bone tuberculosis
Pulmonary tuberculosis
Undiagnosed
Other diseases
Neonatal diseases
Congenital malformations||tt| |Cerebrovascular disease
Vibratory viscera
Jingtongli
Theocratic family
Mental illness
Salt end
Division of disease
Death by inhalation
Parasitic disease
Infectious disease
Tuberculosis
Lion's symptom
Malignant tumors other than cancer
9()(8)
（2）
(9)[(s)
()(8)()
GB 16853--1997
(2)=(22)+(92)(92)+($2)+(82)+(22): Si(22)=(88)+(28)+(18)+(08)+(62)+(82)"Si (22) = (88) + (28) + (18) + (08) + (62) + (82)"Si (22) = (88) + (28) + (18) + (08) + (62) + (82)"Si (22) = (88) + (28) + (18) + (08) + (62) + (82)"Si (22) = (88) + (28) + (18) + (08) + (62) + (82)"Deaths not caused by tuberculosis. 4
5 Migration: Those who have moved out of the county and will no longer visit the county tuberculosis prevention and control center (department) for treatment and reexamination. 6 Lost: Patients who have refused treatment or examination after repeated follow-up or whose whereabouts are unknown for one year. 7 Completed treatment without sputum results: Patients who completed the prescribed course of treatment but had no sputum results or only one negative sputum smear result. Those who cannot be included in the above items are included in the "other" item. The "other" items need to state the reasons for inclusion and the number of patients. 8
9 If a short-term chemotherapy regimen is used, the items in Table A8 are the results of the full course of treatment. 490
Number of live births
Number of people sampled
GB16853—1997
BCG vaccination of newborns in the year
Number of people vaccinated with BCG
Intradermal method
Table A10 Card marks and card establishment of children aged 12 months Number of people with card marks
Table A11
Incidence of tuberculous encephalopathy aged 0 to 14 years (number of people)
Instructions for filling in the form: If there are no cases of tuberculous encephalopathy after the survey, write \0 in both the male and female columns of the total. Table A12|| tt||BCG type:
Number of people vaccinated
Test reaction
Production unit:
Newborn BCG vaccination 12 weeks positive conversion reaction diameter, mm
13~～
Reaction diameter, mm
Vaccination method:
Type of BCG:
Production unit:
Number of people with complications from BCG vaccination
Table A13
Ulcers for 6 months
More than 6 months have not healed
Note: "Other" should indicate the name of the disease.
Keloid
Allergic purpura
Osteomyelitis
Scratch
Number of people with cards
Lymph node enlargement
Degenerative changes
Acute lung disease
Cor pulmonale
Telescopic surgery
Renal tuberculosis
Bone tuberculosis
Pulmonary tuberculosis
Undiagnosed
Other diseases
Neonatal diseases
Congenital malformations shape
cerebrovascular disease
hard organ
nervous system
theology
mental illness
coagulation
generation disease
sucking death
parasitic disease
infectious disease
tuberculosis
lion
malignant tumor other than cancer
9()(8)
（2）
(9)[(s)
()(8)()
GB 16853--1997
(2)=(22)+(92)(92)+($2)+(82)+(22): Si(22)=(88)+(28)+(18)+(08)+(62)+(82)"Deaths not caused by tuberculosis. 4
5 Migration: Those who have moved out of the county and will no longer visit the county tuberculosis prevention and control center (department) for treatment and reexamination. 6 Lost: Patients who have refused treatment or examination after repeated follow-up or whose whereabouts are unknown for one year. 7 Completed treatment without sputum results: Patients who completed the prescribed course of treatment but had no sputum results or only one negative sputum smear result. Those who cannot be included in the above items are included in the "other" item. The "other" items need to state the reasons for inclusion and the number of patients. 8
9 If a short-term chemotherapy regimen is used, the items in Table A8 are the results of the full course of treatment. 490
Number of live births
Number of people sampled
GB16853—1997
BCG vaccination of newborns in the year
Number of people vaccinated with BCG
Intradermal method
Table A10 Card marks and card establishment of children aged 12 months Number of people with card marks
Table A11
Incidence of tuberculous encephalopathy aged 0 to 14 years (number of people)
Instructions for filling in the form: If there are no cases of tuberculous encephalopathy after the survey, write \0 in both the male and female columns of the total. Table A12|| tt||BCG type:
Number of people vaccinated
Test reaction
Production unit:
Newborn BCG vaccination 12 weeks positive conversion reaction diameter, mm
13~～
Reaction diameter, mm
Vaccination method:
Type of BCG:
Production unit:
Number of people with complications from BCG vaccination
Table A13
Ulcers for 6 months
More than 6 months have not healed
Note: "Other" should indicate the name of the disease.
Keloid
Allergic purpura
Osteomyelitis
Scratch
Number of people with cards
Lymph node enlargement
Degenerative changes
Acute lung disease
Cor pulmonale
Telescopic surgery
Renal tuberculosis
Bone tuberculosis
Pulmonary tuberculosis
Undiagnosed
Other diseases
Neonatal diseases
Congenital malformations shape
cerebrovascular disease
hard organ
nervous system
theology
mental illness
coagulation
generation disease
sucking death
parasitic disease
infectious disease
tuberculosis
lion
malignant tumor other than cancer
9()(8)
（2）
(9)[(s)
()(8)()
GB 16853--1997
(2)=(22)+(92)(92)+($2)+(82)+(22): Si(22)=(88)+(28)+(18)+(08)+(62)+(82)"
Tip: This standard content only shows part of the intercepted content of the complete standard. If you need the complete standard, please go to the top to download the complete standard document for free.